Atmofizer Technologies Inc. (the “Company” or “Atmofizer”) (CSE: ATMO) (Frankfurt: J3K) is pleased to announce that the Company has entered into a non-exclusive distribution agreement with USA Rapid Test, LLC (“USA Rapid Test”) under which USA Rapid Test has placed an initial purchase order for US$4.2 million personal space, Atmofizer A500s.USA Rapid Test, based out…
Atmofizer Technologies Inc. Signs Distribution Partnership with USA Rapid Test
More from InformationalMore posts in Informational »
- UV Business News – Trung T. Doan Now Holds Majority of SEMILeds Common Stock After SEC Filing 13D
- Professional Opion – UVC Is Needed For Public / Health Care Pathogen Disinfection
- Use of Multispectral Imaging Including UV For Reviewing Famous Manuscripts To Find New Text
- NY Governor Hochul Announces $340 M For Local Water Infrastructure Projects
- UV Blood Irradiation To Help Patients Fight Infection